Development of a vaccine to prevent pneumocystis pneumonia
Ended Project Grant Awarded Last action
- Award ID
- R41AI145416
- Recipient
-
NXT Biologics, Inc. UEI MB9ADR23X1L8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $272,439
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Georgia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $272,439 |
Quick answers
Who received award R41AI145416?
R41AI145416 was awarded to NXT Biologics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 1, 2020.
How much is award R41AI145416 worth?
$272,439 has been obligated on R41AI145416.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award